Drug Keytruda May Help Block Melanoma's Return

05:00 EDT 16 Apr 2018 |

MONDAY, April 16, 2018 -- Taking the drug Keytruda after surgery for advanced melanoma significantly reduced patients' risk of their cancer returning, a new study found. Last May, Keytruda (pembrolizumab) became the first ever drug approved by the...

Original Article: Drug Keytruda May Help Block Melanoma's Return


More From BioPortfolio on "Drug Keytruda May Help Block Melanoma's Return"

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Surgical treatments
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...

Skin cancers
There are three main types of skin cancer: basal cell carcinoma, squamous cell carcinoma and malignant melanoma. Basal cell carcinoma Basal cell carcinoma, or BCC, is a cancer of the basal cells at the bottom of the epidermis. It’s very common ...